The school's scientific research is based on the international frontier, giving full play to the advantages of a complete range of pharmacy and traditional Chinese medicine disciplines. Through the construction of subject groups, it promotes the intersection and penetration of disciplines, and significantly improves its scientific and technological innovation capabilities. The school currently has the National Key Laboratory of "Active Components and Efficacy of Natural Drugs", and has built 30 national and provincial key laboratories, technology platforms, and engineering technology centers related to various nodes of preclinical innovative drug research and development, and has " "Institute of Pharmaceutical Sciences" promotes the school's research and development of new drugs as a whole and provides all-round services for the research and development of various new drugs. During the “Eleventh Five-Year Plan” and “Twelfth Five-Year Plan” periods, the number of approved national “major new drug creation” major science and technology projects and the number of funds ranked first among universities in the country. In the past five years, 460 National Natural Science Foundation projects have been approved, with a funding of 240 million yuan, including 19 large projects with a funding of 62.2762 million yuan. In 2018, 2 national key R&D plans were approved. Since the “Thirteenth Five-Year Plan”, the school has won national science and technology awards for five consecutive years, including 4 scientific and technological progress awards and 1 technological invention award; it has obtained 2 national new drug certificates, 18 new drug clinical approval documents, and 629 authorized invention patents; published SCI More than 4,000 papers. In recent years, the school has successively developed first-class innovative drugs and new drugs, including cyclohexine hydrochloride, aprelate, edaravone, ginkgolide injection, irinotecan, vinorelbine and Yingtaiqing. There are nearly 100 preparations, which have brought huge economic benefits to the company. It has signed more than 4,200 cooperation agreements with more than 1,000 pharmaceutical companies, with a total project amount of more than 1.6 billion yuan, and has become an important engine to promote the development of the pharmaceutical industry.
The school focuses on national drug policy and industrial economics, and devotes itself to the construction of think tanks. The "National Drug Policy and Pharmaceutical Industry Economics Research Center" and the "National Licensed Pharmacist Development Research Center" provide important intellectual support for my country's pharmaceutical industry and government decisions such as drug pricing, drug supervision, and pharmacist legislation.